Insulet's Q3 Earnings: A Key Healthcare Tech Indicator
Update: 2025-11-05
Description
Insulet Corporation's third quarter earnings report is set to be released this Thursday, with investors eagerly anticipating the results. The insulin delivery company, trading under PODD, has a history of surpassing Wall Street's revenue predictions, and analysts expect this trend to continue. Forecasts suggest a twenty-four point nine percent year-over-year revenue growth, with adjusted earnings per share projected at one dollar and fourteen cents. Insulet's performance often provides insights into the broader healthcare technology landscape, making this report a key indicator for the industry.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
